Tag Archives: MRA Contrast Agent

Gadolinium MRA Contrast Agent Approved by FDA with Warnings about Nephrogenic Systemic Fibrosis

December 30, 2008 By: AboutLawsuits

The FDA has approved a new gadolinium-based contrast agent, Vasovist Injection, which is the first imaging agent approved for use during Magnetic Resonance Imaging (MRA) examinations.

Problems with Philips CPAP Machines Reported 11 Years Before Recall Issued By Manufacturer (Posted 5 days ago)

A ProPublica report reveals that Philips officials hid thousands of reports of problems with sound abatement foam used in millions of CPAP machines, failing to recall the devices for more than a decade after receiving the first complaints.

Suboxone Dental Side Effects Caused Permanent Damage to Teeth, Lawsuit Claims (Posted 6 days ago)

A Suboxone lawsuit claims the opioid addiction treatment's dental side effects can lead to severe tooth damage and decay.

Ozempic Intestinal Blockage Warnings Added to FDA Label About Gastrointestinal Risks (Posted 6 days ago)

The FDA is requiring new label warnings to alert patients and doctors to the risk of Ozempic intestinal blockage side effects.

Tag Archives: MRA Contrast Agent

Gadolinium MRA Contrast Agent Approved by FDA with Warnings about Nephrogenic Systemic Fibrosis

More Top Stories

Review A Case